Dr. Philip McMillan, John McMillan
When Shane Warne died suddenly in a Thai hotel room in March 2022 at the age of 52, the world lost one of cricket’s most gifted performers. Within hours, two competing explanations emerged. The official medical finding pointed to a heart attack driven by arterial plaque. His son Jackson had a different reading. “Even if dad had underlying health issues, I think this brought it straight to the surface,” he said, referring to the COVID vaccine.
The medical establishment pushed back sharply. Researchers were quoted insisting that the type of heart attack Warne suffered had no connection to myocarditis or pericarditis, the cardiac complications most commonly associated with COVID vaccination. Case closed, it seemed.
Except it isn’t. Not by a long way.
Warne carried real cardiovascular risk: a history of smoking, heavy drinking, and a strong family history of heart disease. He was already seeing a cardiologist. These facts belong in any honest account of his death, and they matter. But the presence of pre-existing risk does not automatically settle the question of whether other factors contributed. In medicine, causes stack. The question worth asking is not whether Warne had a heart attack (he did) but whether something accelerated the process that killed him, and whether that something is now silently at work in many others.
When Plaque Is More Than Cholesterol
To understand why that question carries such weight, it helps to understand what arterial plaque disease actually is. The popular image is pipes slowly furred up with fat. The biological reality is more complicated, and more alarming.
Arterial plaques are largely constructed from macrophages, the immune system’s frontline scavenging cells, that have ingested oxidised LDL cholesterol and become trapped inside arterial walls. Plaque disease is, at its core, an inflammatory condition. This is why statins do more than simply lower cholesterol. Their anti-inflammatory effect on macrophages stabilises plaques, making them less likely to rupture. A stable plaque may be dangerous in the long term; an unstable, inflamed plaque is dangerous right now. The distinction matters enormously when considering what a powerful new inflammatory trigger might do to arterial tissue that is already compromised.
And SARS-CoV-2 is precisely such a trigger.
Research into severe COVID-19 and long COVID has consistently pointed to macrophage overactivation as a central mechanism of harm. In the post-infection state, this overactivation can drive damage across multiple organ systems. The cardiovascular system is not spared. When macrophages already embedded in arterial plaques encounter a fresh wave of inflammatory signalling, the risk of plaque destabilisation rises, and with it, the risk of the kind of sudden cardiac event that killed Shane Warne.
The Spike Protein Problem
The source of that inflammatory signal is where the public debate has become unhelpfully tribal. One camp attributes any post-pandemic cardiovascular risk entirely to infection; another insists concerns relate only to vaccine-derived spike protein. Dr. Philip McMillan, whose clinical and research work has tracked post-COVID cardiovascular patterns in detail, rejects both positions as incomplete.
“I don’t differentiate where the spike protein comes from,” he has said. “Some people say it’s only the infection, some people say only the vaccine. I say the combination is the danger.”
The mechanism is biologically coherent. Spike protein, regardless of origin, triggers immune activation. In someone with established plaque disease, that activation may do considerably more than cause temporary inflammation. It may accelerate the instability of plaques that have been quietly developing for years. In Warne’s case, whether a recent infection, recent vaccination, or some interaction of both contributed to the timing of his death cannot be determined. The pathological data required to answer the question, including what physicians call microscarring, subtle scarring of cardiac tissue that signals prior inflammatory insult, was never publicly reported. Whether it was present, and whether it played any role in the fatal arrhythmia that appears to have ended his life, remains an open question to which nobody is currently seeking an answer.
What a Major Study Found, and What It Left Unanswered
A large population-based study published in PLOS Medicine examined 4,963 sudden deaths among Ontario residents aged 12 to 50 between April 2021 and June 2023. Its headline finding was widely reported: vaccination was associated with a lower risk of sudden cardiac death overall. What drew far less attention was a different number buried within the same dataset.
Individuals who had experienced a confirmed SARS-CoV-2 infection within the 90 days before their death were more than twice as likely to appear in the sudden death cohort as in the control group. The adjusted odds ratio was 2.36. Among cases, 2.2% had a recent infection, compared with 0.9% of living controls. That is not a marginal signal. It is a finding of genuine clinical significance, pointing directly toward the window of post-infection cardiovascular vulnerability that Dr. McMillan’s macrophage hypothesis would predict.
The study did not cross-tabulate vaccination status among those who had died with a recent infection. The interaction between immune priming and subsequent exposure, precisely the combination identified as most concerning, was left unexamined. That is not a failure of the researchers. Population studies cannot answer every question at once. But it marks the exact boundary of current knowledge, and that boundary needs to move urgently.
A Pattern Hiding in Plain Sight
The Toronto study sits within a broader picture that is becoming harder to dismiss. UK hospital episode data has recorded striking rises in cardiovascular diagnoses since 2020 and 2021. Hypertensive heart disease is up 189%. Cerebral arterial occlusion has risen by 50%. Myocarditis is up 50%. These figures do not describe a population whose heart health has passed through the pandemic unscathed.
No single dataset proves causation. Correlation is not mechanism. But when a plausible biological pathway, a significant finding in a large population study, and a pattern of climbing clinical diagnoses all point in the same direction, the appropriate scientific response is to look harder, not to declare the matter resolved and move on.
The Research That Has to Happen
Shane Warne’s death will not be the last case to prompt this conversation. The trajectory of cardiovascular disease in the post-COVID era suggests that many more are coming, and that the public debate around each one will be just as polarised and just as poorly informed as it was in 2022.
The question of whether spike protein accelerates plaque disease in people who already carry cardiovascular risk is answerable. Longitudinal plaque imaging studies, post-mortem tissue analysis for spike protein localisation in arterial walls, and long-term follow-up of cohorts with documented pre-existing cardiovascular disease would all generate the evidence needed. The biological rationale is established. The tools are available. What is absent is the funding, and behind the funding, the political will to commission research that might return uncomfortable findings.
That discomfort is not a reason to avoid the work. It is precisely why the work is necessary. Patients with pre-existing heart disease are entitled to clinical guidance that accounts for their specific risk profile in a world where spike protein exposure, from infection, from vaccination, or from both, is now a permanent feature of the epidemiological landscape. Families who have lost someone suddenly and young are entitled to an honest scientific answer, not a deflection. And populations carrying the silent burden of arterial plaque are entitled to know whether a mechanism that is biologically plausible and epidemiologically signalled is quietly shortening their odds.
The questions raised by Shane Warne’s death are not fringe claims or political provocations. They are the kind of questions that good science exists to answer. The longer they go unexamined, the more cases will accumulate without explanation, and the higher the cost of having looked away.
0 Comments